|

Flutamide Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid +31 more

Pipeline

Phase 3: 2

Top Sponsors

  • SWOG Cancer Research Network1
  • NRG Oncology1

Indications

  • Cancer2
  • Metastatic Prostatic Adenocarcinoma1
  • Castration Levels of Testosterone1
  • Stage IVB Prostate Cancer AJCC v81
  • Stage IVA Prostate Cancer AJCC v81

Birmingham, Alabama1 trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

University of Alabama at Birmingham Cancer Center

Phase 3

Gilbert, Arizona1 trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Banner MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.